| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.056 | 0.2 |